Akums Drugs and Pharmaceuticals IPO vs Bansal Wire IPO

Comparision between Akums Drugs and Pharmaceuticals IPO and Bansal Wire IPO.

IPO Details

Akums Drugs and Pharmaceuticals IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Bansal Wire IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Akums Drugs and Pharmaceuticals IPO	Bansal Wire IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE, NSE	BSE, NSE
Lead Managers	ICICI Securities Limited Axis Bank Limited Citigroup Global Markets India Private Limited Ambit Private Limited	SBI Capital Markets Limited Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd)
Registrar	Link Intime India Private Ltd	Kfin Technologies Limited
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor	Anchor Investor	Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Akums Drugs and Pharmaceuticals IPO is up to ₹1,856.74 Cr whereas the issue size of the Bansal Wire IPO is up to ₹745.00 Cr. The final issue price of Akums Drugs and Pharmaceuticals IPO is ₹679.00 per share and of Bansal Wire IPO is ₹256.00 per share.

	Akums Drugs and Pharmaceuticals IPO	Bansal Wire IPO
Face Value	₹2 per share	₹5 per share
Issue Price (Lower)	₹646.00 per share	₹243.00 per share
Issue Price (Upper)	₹679.00 per share	₹256.00 per share
Issue Price (Final)	₹679.00 per share	₹256.00 per share
Discount (Retail)
Discount (Employee)	₹64.00 per share
Market Lot Size	22 shares	58 shares
Fresh Issue Size	1,00,14,727 shares	2,91,01,562 shares
Fresh Issue Size (Amount)	up to ₹680.00 Cr	up to ₹745.00 Cr
OFS Issue Size	1,73,30,435 shares
OFS Issue Size (Amount)	up to ₹1,176.74 Cr
Issue Size Total	2,73,45,162 shares	2,91,01,562 shares
Issue Size Total (Amount)	up to ₹1,856.74 Cr	up to ₹745.00 Cr

IPO Timetable

Akums Drugs and Pharmaceuticals IPO opens on Jul 30, 2024, while Bansal Wire IPO opens on Jul 03, 2024. The closing date of Akums Drugs and Pharmaceuticals IPO and Bansal Wire IPO is Aug 01, 2024, and Jul 05, 2024, respectively.

	Akums Drugs and Pharmaceuticals IPO	Bansal Wire IPO
Anchor Bid Date	Jul 29, 2024	Jul 02, 2024
Issue Open	Jul 30, 2024	Jul 03, 2024
Issue Close	Aug 01, 2024	Jul 05, 2024
Basis Of Allotment (Tentative)	Aug 02, 2024	Jul 08, 2024
Initiation of Refunds (Tentative)	Aug 05, 2024	Jul 09, 2024
Credit of Share (Tentative)	Aug 05, 2024	Jul 09, 2024
Listing date (Tentative)	Aug 06, 2024	Jul 10, 2024
Anchor Lockin End date 1	Sep 01, 2024	Aug 07, 2024
Anchor Lockin End date 2	Oct 31, 2024	Oct 06, 2024

Financials

Akums Drugs and Pharmaceuticals IPO P/E ratio is , as compared to Bansal Wire IPO P/E ratio of 41.41.

Akums Drugs and Pharmaceuticals IPO

Bansal Wire IPO

Financial

Akums Drugs and Pharmaceuticals Limited Financial Information (Restated Consolidated)

Akums Drugs and Pharmaceuticals Limited's revenue increased by 13.81% and profit after tax (PAT) dropped by -99.19% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	3,516.37	3,266.53	3,069.05
Revenue	4,212.21	3,700.93	3,694.52
Profit After Tax	0.79	97.82	-250.87
Net Worth	709.50	717.19	621.98
Reserves and Surplus	861.01	868.70	787.79
Total Borrowing	491.56	536.97	357.95
Amount in ₹ Crore

Bansal Wire Industries Limited Financial Information (Restated)

Bansal Wire Industries Limited's revenue increased by 1.99% and profit after tax (PAT) rose by 31.48% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	1,264.01	749.05	695.48
Revenue	2,470.89	2,422.57	2,205.07
Profit After Tax	78.80	59.93	57.29
Net Worth	422.37	282.51	223.01
Reserves and Surplus	358.64	273.41	213.91
Total Borrowing	681.14	422.19	413.15
Amount in ₹ Crore

Promoter Shareholding (Pre-Issue)

84.94%

73.60%

Promoter Shareholding (Post-Issue)

59.92%

P/E Ratio

41.41

Market Cap

₹4007.83 Cr.

ROE

0.11%%

21.19%%

ROCE

3.37%%

18.46%%

Debt/Equity

0.69

1.48

EPS

₹6.18

RoNW

-0.57%

18.27%%

Shares Offered

In the Akums Drugs and Pharmaceuticals IPO retail investors (RII) are offered 27,12,424 shares while in Bansal Wire IPO retail investors are offered 27,12,424 shares. Qualified institutional buyers (QIB) are offered 81,37,276 shares in Akums Drugs and Pharmaceuticals IPO and 58,20,313 shares in Bansal Wire IPO.

	Akums Drugs and Pharmaceuticals IPO	Bansal Wire IPO
Anchor Investor Reserveration	1,22,05,912 shares	87,30,468 shares
Market Maker Reserveration
QIB	81,37,276 shares	58,20,313 shares
NII	40,68,637 shares	43,65,234 shares
RII	27,12,424 shares	1,01,85,547 shares
Employee	2,43,902 shares	0 shares
Others
Total	1,51,62,239 shares	2,03,71,094 shares

Bids Received (Subscription)

Akums Drugs and Pharmaceuticals IPO subscribed 63.44x in total, whereas Bansal Wire IPO subscribed 62.76x.

	Akums Drugs and Pharmaceuticals IPO	Bansal Wire IPO
QIB (times)	90.09x	153.86x
NII (times)	42.10x	54.21x
Big NII (times)	47.43x	55.27x
Small NII (times)	31.45x	52.11x
RII (times)	20.80x	14.37x
Employee (times)	4.14x
Other (times)
Total (times)	63.44x	62.76x

Compare with others

Akums Drugs and Pharmaceuticals IPO	Bansal Wire IPO
Interarch Building Products IPO	Unicommerce eSolutions IPO
Orient Technologies IPO	Brainbees Solutions (Firstcry) IPO
Unicommerce eSolutions IPO	Ceigall India IPO
Brainbees Solutions (Firstcry) IPO	Akums Drugs and Pharmaceuticals IPO
Ceigall India IPO	Sanstar IPO
Sanstar IPO	Emcure Pharma IPO
Bansal Wire IPO	OLA Electric IPO
Emcure Pharma IPO	Vraj Iron and Steel IPO
OLA Electric IPO	Aasaan Loans IPO
Vraj Iron and Steel IPO	Stanley Lifestyles IPO

Comments

Add a public comment...